
5.27 Delayed Data As of Aug 11 | ![]() Today’s Change | 3.02 Today|||52-Week Range 19.46 | -22.04% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Acumen Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 27.00 and a low estimate of 9.00. The median estimate represents a +184.63% increase from the last price of 5.27.
The current consensus among 5 polled investment analysts is to Buy stock in Acumen Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.